Major Cancer Research Center Signs New $3.5 Million, Multiyear Commitment to OmniComm's TrialMaster® EDC

Stock Information for OmniComm Systems Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OmniComm Systems Inc

Rundo Selects OmniComm's TrialMaster® and TrialOne® eClinical Solutions
OmniComm Launches TrialOne® Express for Early Stage Research
OmniComm Systems, Inc. Reports Financial Results for the Year Ending December 31, 2018
International CRO Signs Agreement With OmniComm Systems for TrialMaster® EDC
European Medical Device Company Signs Multiyear Agreement to Use OmniComm's TrialMaster® EDC for Ophthalmological Research
KKS Düsseldorf Signs Multiyear Deal for OmniComm's TrialMaster® EDC Technology
Top 5 Global CRO Places Contract for OmniComm's Newly Released Leading-Edge AutoEncoder
Hitachi Inspharma Partners With OmniComm to Offer eClinical Solutions in Japan

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.